U.S. Cancer In-Vitro Diagnostics Markets

 


This research service provides market intelligence, analysis, and forecasts for the U.S. cancer in-vitro diagnostics markets. The products discussed in this research service are cancer in vitro diagnostic kits, consumables, and instruments. A detailed analysis is provided with regard to these products and the companies that manufacture and distribute them. The forecast period is 2006 through 2012 with 2005 as the base year.

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

Table of Contents

U.S. Cancer In-Vitro Diagnostics Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Cancer In-Vitro Diagnostics Markets, Total U.S. Cancer In-Vitro Diagnostics MarketMarket OverviewIntroductionResearch MethodologyMarket Engineering AnalysisDemand AnalysisSelect Cancer ProfilesRevenue ForecastsScope and SegmentationMarket ForecastsMarket Challenges and Strategic RecommendationsIndustry ChallengesStrategic RecommendationsTotal Market Forces and TrendsTotal Market DriversTotal Market RestraintsMarket and Technology TrendsEmerging Market - Protein Isoform TestingIntroduction to Isoform DiagnosticsU.S. Cancer In-Vitro Diagnostics Markets, U.S. Nucleic Acid Testing Cancer Diagnostics MarketOverviewIntroductionScope and SegmentationMarket Engineering MeasurementsMarket Drivers and RestraintsMarket DriversMarket RestraintsMarket Forecasts and Product AnalysisRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive LandscapeMarket Share AnalysisU.S. Cancer In-Vitro Diagnostics Markets, U.S. Immunoassay Cancer Diagnostics MarketOverviewIntroductionScope and SegmentationMarket Engineering MeasurementsMarket Drivers and RestraintsMarket DriversMarket RestraintsMarket Forecasts and Product AnalysisRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive LandscapeMarket Share AnalysisU.S. Cancer In-Vitro Diagnostics Markets, U.S. Advanced Staining Cancer Diagnostics MarketOverviewIntroductionScope and SegmentationMarket Engineering MeasurementsMarket Drivers and RestraintsMarket DriversMarket RestraintsMarket Forecasts and Product AnalysisRevenue ForecastsProduct AnalysisCompetitive AnalysisCompetitive LandscapeMarket Share AnalysisU.S. Cancer In-Vitro Diagnostics Markets, AppendixDecision Support DatabaseGlobal Cancer IncidenceBladder Cancer Incidence and MortalityBreast Cancer Incidence and MortalityColorectal Cancer Incidence and MortalityLiver Cancer Incidence and MortalityLung Cancer Incidence and MortalityProstate Cancer Incidence and MortalityStomach Cancer Incidence and MortalitySmoking Prevalence and Cigarette Consumption




Related Research

Release Date : 11-Aug-17

Region : North America

Release Date : 10-Aug-17

Region : North America

Release Date : 09-Aug-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.